According to a recent New York Times article, the FDA is aiming to roll out vaccines for children under 5 in June. Moderna and Pfizer-BioNTech vaccines are both under review, and the companies have asked the agency for approval to administer them to the youngest Americans. Here’s the tentative timeline:
- On June 7, FDA intends to convene VRBPAC to discuss an EUA request for a COVID-19 vaccine manufactured by Novavax to prevent COVID-19 in individuals 18 years of age and older.
